HIGHLIGHTS
- who: Pierre-Michel Llorca from the Department of Psychiatry, Clermont-Ferrand University Hospital, Clermont Auvergne University, Clermontu2011Ferrand, France have published the Article: Place of the partial dopamine receptor agonist aripiprazole in the management of schizophrenia in adults: a Delphi consensus study, in the Journal: (JOURNAL)
- what: The aim of this study was to capture experience with aripiprazole in psychiatric practice to shed light on some of these less well-documented aspects of the clinical profile of aripiprazole. The authors initially fixed a target of 60-70 participants, to ensure that around thirty completed both rounds . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.